Ongoing Implications of the COVID‐19 Pandemic Environment on Esophageal Cancer Characteristics and Treatment in the United States
Compared to the pre-pandemic year, patients diagnosed with esophageal cancer in in the United States during pandemic-year-two experienced delays to treatment, possibly due to a growing back log of cases.
Authors
- Ana Gleisner (ORCID: https://orcid.org/0000-0002-5040-4105)
- John D. Mitchell (ORCID: https://orcid.org/0000-0003-0045-2288)
- Christina M. Stuart (ORCID: https://orcid.org/0000-0002-9851-8486)
- Robert A. Meguid (ORCID: https://orcid.org/0000-0003-2646-4252)
- Martin D. McCarter (ORCID: https://orcid.org/0000-0001-8174-1713)
- Michael R. Bronsert (ORCID: https://orcid.org/0000-0003-1879-6193)
- Nicole M. Mott (ORCID: https://orcid.org/0000-0003-4834-3400)
- Benedetto Mungo
- Simran Randhawa (ORCID: https://orcid.org/0000-0002-5234-7108)
- Salvador Rodriguez Franco (ORCID: https://orcid.org/0000-0001-9786-3651)
- Elizabeth A. David
Institutions
- University of Colorado Anschutz Medical Campus (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Journal of Surgical Oncology
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1002/jso.70004
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00